Purple Biotech Ltd
PPBT
$2.30
$0.0251.10%
NASDAQ
| 06/30/2024 | 06/30/2024 | 03/31/2024 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -31.91% | -31.91% | -29.57% | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | -- | -- | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -13.69% | -13.69% | 220.47% | ||
| Total Current Assets | -31.03% | -31.03% | -27.78% | ||
|
|
|||||
| Total Current Assets | -31.03% | -31.03% | -27.78% | ||
| Net Property, Plant & Equipment | -13.91% | -13.91% | -11.28% | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -0.72% | -0.72% | 0.00% | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | -- | -- | -- | ||
| Total Assets | -9.53% | -9.53% | -10.02% | ||
|
|
|||||
| Total Accounts Payable | -12.51% | -12.51% | -1.56% | ||
| Total Accrued Expenses | -23.42% | -23.42% | -19.12% | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | -2.15% | -2.15% | -1.06% | ||
| Total Finance Division Other Current Liabilities | -46.29% | -46.29% | -18.75% | ||
| Total Other Current Liabilities | -46.29% | -46.29% | -18.75% | ||
| Total Current Liabilities | -24.00% | -24.00% | -12.28% | ||
|
|
|||||
| Total Current Liabilities | -24.00% | -24.00% | -12.28% | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -34.71% | -34.71% | -25.77% | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | 0.00% | 0.00% | 0.00% | ||
| Total Liabilities | -23.76% | -23.76% | -12.32% | ||
|
|
|||||
| Common Stock & APIC | 1.42% | 1.42% | 0.38% | ||
| Retained Earnings | -1.70% | -1.70% | -2.74% | ||
| Treasury Stock & Other | -3.11% | -3.11% | 0.16% | ||
| Total Common Equity | -5.49% | -5.49% | -9.32% | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | -5.49% | -5.49% | -9.32% | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -14.08% | -14.08% | -21.11% | ||
| Total Equity | -5.51% | -5.51% | -9.35% | ||
|
|
|||||